Stanford Bio-X Frontiers in Interdisciplinary Biosciences Seminar

DARLENE SOLOMON, AGILENT

Dr. Darlene Solomon is senior vice president and chief technology officer for Agilent Technologies. Her responsibilities include Agilent Research Laboratories which focuses on high impact, longer range research in support of Agilent's sustained business growth, and Agilent's programs in university relations, external research and venture investment. In her leadership role, she works closely with Agilent's businesses to define the company's technology strategy and R&D priorities.

Stanford bio-X Frontiers in Interdisciplinary Biosciences Seminar

BRYAN ROTH, UNIVERSITY OF NORTH CAROLINA

This seminar has been canceled. Please join us for future seminars.

Stanford Bio-X Frontiers in Interdisciplinary Biosciences Pre-Seminar

RON DROR, DEPARTMENT OF COMPUTER SCIENCE

Attend Dr. Dror's pre-seminar presentation to learn more about Dr. Bryan Roth's seminar, "Molecular insights into psychoactive drug actions", to be held Thursday, November 15th.

Featuring talks from Stanford Faculty:

 Lisa Giocomo
 H. Craig Heller
 Dennis Wall

Featuring talks from Stanford Faculty:

 Ravindra Majeti
 Peter Santa Maria
 Anson Lee

Featuring talks from Stanford Faculty:

 Helen Blau
 Paul Wang
 Eric Appel

Stanford bio-X Frontiers in Interdisciplinary Biosciences Seminar

DARIA MOCHLY-ROSEN, DEPARTMENT OF CHEMICAL & SYSTEMS BIOLOGY

Dr. Daria Mochly-Rosen founded the SPARK program to provide a cost-effective model to generate proof of concept using industry standards. Since 2006, SPARK has advanced scores of new diagnostics and drugs to the clinic and commercial sectors and educated hundreds of faculty, postdoctoral fellows, and students on the translational process. Dr. Mochly-Rosen's research lab is a multi-disciplinary lab that includes chemists, biochemists, biologists and physician scientists. They develop pharmacological agents and apply them to understand molecular and cellular events under basal and disease conditions using in vitro, in culture and in vivo models.

Stanford Bio-X Frontiers in Interdisciplinary Biosciences Seminar

SYLVAINE CASES, JOHNSON & JOHNSON INNOVATION

Dr. Cases's is the Vice President of Oncology Scientific Innovation at Johnson & Johnson Innovation in California. She has significant experience in the fields of cancer biology and metabolism, with more than 16 years in research and drug discovery in both pharma and biotech.

Stanford bio-X Frontiers in Interdisciplinary Biosciences Seminar

BOZHI TIAN, UNIVERSITY OF CHICAGO

Recent studies have demonstrated that in addition to biochemical and genetic interactions, cellular systems also respond to biophysical cues, such as electrical, thermal, and mechanical signals. However, we only have limited tools that can introduce localized physical stimuli and/or sense cellular responses with high spatiotemporal resolution. Dr. Tian's group integrates material science with biophysics to study several semiconductor-based biointerfaces.

Stanford Bio-X Frontiers in Interdisciplinary Biosciences Pre-Seminar

BIANXIAO CUI, DEPARTMENT OF CHEMISTRY

Attend Dr. Cui's pre-seminar presentation to learn more about Dr. Bozhi Tian's seminar, "Physical biology at the semiconductor-enabled biointerfaces", to be held Thursday, October 4th.